Cure Express: Reinforcing Patient Safety & Clinical Reliability through Excellence in Healthcare Innovation

Parik Pahwa & Sainyum Pawah, Director

Parik Pahwa & Sainyum Pawah

Director

Driven by numerous government initiatives towards making quality care accessible to all and an ever-increasing population, the Indian healthcare ecosystem has been thriving incessantly in recent times, with the demand for medical disposables at an all-time high today.

As per IMARC Group’s recent report, the Indian medical disposables market, which stood at $23 billion in 2024, is expected to hit $49 billion by 2034, growing at an 8.48 percent CAGR during the forecast period.

However, there has been a significant shift in market dynamics post the COVID pandemic; both healthcare providers as well as patients now lay prime emphasis on the safety and reliability of medical disposables and other products that are used for treatments in healthcare setups.

Amidst such dynamic market conditions, one company that stands-out through its customer-centric and quality conscious business practices is Cure Express. Based in Faridabad, Cure Express was incepted in 2024 by Parik Pahwa and Sainyum Pawah (Directors) with a vision to bridge the gap between reliable medical disposables and growing demand for healthcare solutions by proving top-notch quality products & services that mirror utmost commitment to consistency, reliability and responsiveness.

Starting its journey with just supplying medical disposables, the company has evolved rapidly in tandem with the dynamics of the healthcare landscape and is today on a mission to enhance the treatment outcomes for patients and strengthen the safety & efficiency of healthcare ecosystems globally.

Sharing his thoughts on the current medical disposables market in India, Parik elucidates, “The medical disposables market is undergoing rapid structural transformation lately, wherein there has been an increased focus by healthcare providers on infection prevention, operational efficiency and supply chain reliability.

Medical disposables are no longer viewed as mere consumables, but rather as critical layers of protection that facilitate patient safety and healthcare resilience. Also, with the regulatory landscape becoming highly stringent, hospitals are now on the constant lookout for value-driven solutions that balance quality, compliance, traceability and affordability”.

We emphasize on strong customer engagement and responsive service, ensuring that healthcare partners receive timely support and solutions tailored to their specific needs

Parik Pahwa & Sainyum Pawah, Director

Exquisite Products Portfolio with Efficient Supply Chain

With a strong market presence across more than 25 countries across the world, Cure Express’ offerings encompass a wide range of products that include medical disposables, hospital furniture, surgical equipment, diagnostics equipment, hospital dressings, and many more.

Usable across diverse healthcare setups such as clinics, hospitals, diagnostic labs and surgical centers, each of these products are designed & manufacturing to stay par with highest levels of international standards in terms of their safety, efficiency and reliability.

Additionally, the company also supports healthcare providers globally to maintain uninterrupted access to quality and efficient care by offering a comprehensive suite of supply chain services as well, including global sourcing, quality assurance, logistics coordination, regulatory compliance support, supply chain optimization, and a lot more.

“At Cure Express, we’re on a mission to ensure that every disposable product we deliver strengthens patient safety and clinical reliability. Thus, our strategic priority is to ensure that healthcare providers can rely on our products consistently, regardless of geographic or operational challenges.

What truly differentiates us is our deep understanding of healthcare operational needs, consistent quality assurance, strict compliance with global standards, and an unwavering commitment towards ensuring that hospitals never have to worry about the availability or quality of essential medical consumables”, adds Parik.

Cure Express also has a separate pharmaceutical divi­sion through which it is engaged in the export of numerous finished formulations such as tablets, capsules, injections, ointments, and oral liquids across diverse therapeutic ar­eas.

Further, it is also active in the nutraceuticals and cos­meceuticals segments wherein it offers a large variety of evidence-based supplements and skincare products that are developing via extensive R&D and using highest qual­ity ingredients.

This way, the company is striving to pro­mote wellness, preventive care and aesthetic enhancement, while simultaneously bridging the gap between traditional healthcare and holistic wellness.

At Cure Express, our strategic priority is to ensure that healthcare providers can rely on our products consistently, regardless of geographic or operational challenges

Quality-Centered & Research-Driven Business Practices

Quality and client-centricity have always been the cornerstones of Cure Express’ service delivery, wherein it leaves no stone unturned to ensure customers get nothing short of the best quality products and services.

As an ISO 9001:2015 and ISO 13485: 2016 certified organization, the company ensures to adhere to highest standards right from the initial product design and procurement to manufacturing the end product and distribution, especially in terms of quality control, risk management, medical device safety, traceability and regulatory compliance.

Also, innovation has been embedded in Cure Express’ DNA wherein its highly experienced in-house R&D team is continually exploring new advancements in materials science, manufacturing automation and clinical usability for enhanced safety and durability of its products by improving its manufacturing efficiency and product design.

“Our R&D philosophy is simple: every improvement must make clinical work easier, safer or more efficient. Em­bracing a feedback-driven approach to innovation, we work closely with distributors, industry experts and healthcare professionals who regularly use our products to gather re­al-world feedback and identify any practical challenges they face in everyday medical procedures.

This unique practice of continuous feedback collection and market analysis has been immensely beneficial for us in identifying new oppor­tunities and regularly tweaking the product designs to facil­itate improved safety, usability or efficiency”, Parik further explains.

Addressing Clients’ Challenges with Utmost Efficiency

When it concerns healthcare-related products and services, fragmented regulatory landscape has often been a rather tough nut to crack for most manufacturers due to the varying guidelines & frameworks across different countries they’re operational in. Adding on to this is the extremely volatile supply chain conditions due to the ongoing geopolitical crises globally.

To address these mission-critical pain points of its clients, Cure Express has created a strong network of local partners and regulatory experts across each geography who help the company maintain full compliance to all necessary regional frameworks, regulations and clinical protocols. On the other hand, it also has a centralized quality control measures & systems in place that facilitate uniform safety and performance standards across all markets.

“By investing in robust quality management systems, diversified sourcing networks and strategic partnerships across global markets, we are striving to create a business model that prioritizes reliability, transparency, and long-term trust with healthcare providers.

Our ability to combine local adaptability with global quality consistency has enables us to have a strong market share in more than 25 international markets. Our responsibility is to ensure that a hospital using our products anywhere in the world experiences the same level of quality and reliability”, proudly asserts Parik.

Exploring beyond Horizons

Going forward, Cure Express plans to further expand its products portfolio, strengthen its manufacturing capabilities, and foray into newer international markets. Further, the company envisions to continue staying aligned with the evolving demands of the healthcare providers by investing in cutting-edge R&D, advanced manufacturing technologies and robust management systems.

Overall in the long run, this distinguished organization aspires to position itself as a globally trusted partner for diverse high-quality medical disposables.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.